The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

BioSyent

  • RX
  • TSX Venture
  • Consumer Products
  • Latest 12.33
  • Currency C$
  • Change 0.38
  • Percent Change 3.18 %
  • Volume 59,121
  • Thu Sep 18, 2014 03:58 PM EDT TSX Venture data delayed 15 minutes.
  • Open 11.95
  • Previous Close 11.95
  • High 12.45
  • Low 11.90
  • Bidx0 12.33
  • Askx0 12.50
  • 52-week High09/18 12.45
  • 52-week Low09/19 2.14
  • Beta 0.291
  • Market Cap 168.01M
  • EPS 0.14
  • P/E 88.071
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $7,832,734
  • Earnings $1,928,028
  • Return on Equity 50.12%

Cash Flow

  • Cash Flow $2,497,799
  • Cash $4,381,137
  • Current Ratio 4.61

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $6,091,532
  • Liabilities $1,236,902
  • Liabilities-to-Equity Ratio 0.25

Price Ratios

  • Price to Sales 21.37
  • Price to Book 34.63
  • Price to Cash Flow 66.65

Event Calendar

Event Last   Next  
Earnings Aug 28 n/a n/a n/a
Surprises n/a n/a n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Sep 19, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

BIOSYENT INC. sources, acquires or in-licences pharmaceutical products and markets these products in Canada. BioSyent Pharma Inc. sells pharmaceutical products, Hedley Tech markets bio and health friendly non-chemical insecticides.

Related Securities
Symbol Type Latest % Chg

Officers

  • Rene C. Goehrum President & C.E.O.
  • Alfred D'Souza V.P. & C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 19
  • Incorporation: Canada,
    Apr 28, 1947
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

170 Attwell Drive
Etobicoke, ON
M9W 5Z5

Phone: (905)-206-0013
Fax: (905)-2061413

rgoehrum@biosyent.com
www.biosyent.com

Ideas & Discussion

Live Discussion of RX on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.